Donor-Derived CD19 CAR Cytokine Induced Killer (CIK) Cells Engineered with Sleeping Beauty Transposon for Relapsed B-Cell Acute Lymphoblastic Leukemia (B-ALL)

▪ Background Immunotherapy using patient-derived CAR T cells has achieved complete remission and durable response in highly refractory populations. However, logistical complexity and high costs of manufacturing autologous viral products limit CAR T cell availability. Allogeneic Cytokine Induced Kill...

Full description

Saved in:

Bibliographic Details
Published in:	Blood 2019-11, Vol.134 (Supplement_1), p.200-200
Main Authors:	Magnani, Chiara F, Gaipa, Giuseppe, Belotti, Daniela, Matera, Giada, Tettamanti, Sarah, Cabiati, Benedetta, Buracchi, Chiara, Fazio, Grazia, Zaninelli, Silvia, Rigamonti, Silvia, Cesana, Stefania, Colombo, Valentina, Cazzaniga, Giovanni, Rovelli, Attilio, Balduzzi, Adriana, Napolitano, Sara, Benedicenti, Fabrizio, Montini, Eugenio, Borleri, Gian Maria, Ferrari, Silvia, Gritti, Giuseppe, Lussana, Federico, Introna, Martino, Rambaldi, Alessandro, Dastoli, Giuseppe, Biondi, Andrea
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!